AMERSA Talks

AMERSA
  • 5.0 (1)
  • MEDICINE

Two new Series Coming Soon in 2026!Frontiers in Substance Use Care: Emerging Topics and Evidence Eight episode podcast series sponsored by Provider’s Clinical Support System – Medication for Opioid Use Disorder (PCSS-MOUD), exploring the evolving landscape of substance use and addiction care.Substance Use Across the Lifespan: Supporting Every Stage Five episodes, each paired with a downloadable toolkit and live companion workshop, sponsored by the Opioid Response Network (ORN). This series explores how substance use care changes across the lifespan—from childhood through older adulthood. Previous SeriesStigma and Substance Use: Rewriting the Narrative.  Eight episodes sponsored by Provider’s Clinical Support System – Medication for Opioid Use Disorder (PCSS-MOUD), exploring the pervasive impact of stigma on individuals and communities affected by substance use disorders (SUD). Innovation in Action: Building Stronger CommunitiesSeven episodes sponsored by the Opioid Response Network (ORN), highlighting cutting-edge programs and collaborative efforts supporting individuals and communities affected by substance use disorders. 

  1. Delivering Age-Friendly Care for Older Adults in Opioid Treatment Programs

    1D AGO

    Delivering Age-Friendly Care for Older Adults in Opioid Treatment Programs

    Learn more about this topic. Download the companion toolkit and register for the follow-up live workshop at https://amersa.org/project/episode-1-delivering-age-friendly-care-for-older-adults-in-opioid-treatment-programs/. Older adults are one of the fastest-growing populations in opioid treatment programs, yet most programs were not designed to address the realities of aging—multimorbidity, mobility limitations, cognitive changes, and social isolation. This episode explores how opioid use disorder treatment must evolve to better support older adults and address fragmented care. Listeners will learn how to apply the geriatric 5Ms framework—What Matters Most, Medication, Mentation, Mobility, and Multicomplexity— in opioid treatment program settings, strengthen cross-system collaboration, and implement practical strategies that promote safety, dignity, and person-centered care. This episode addresses critical gaps in integrating geriatric principles into addiction treatment practice. Timestamps: [00:00:41] Episode framing: older adults are the fastest-growing population in opioid treatment programs[00:01:08] Why treatment must evolve for ageing-related needs, fragmented care, and age-insensitive systems[00:03:06] Learning objectives: challenges, the 5Ms framework, and practical age-friendly care strategies[00:04:11] Why older adults in OTPs are increasing, including Medicare coverage and accelerated ageing with OUD[00:05:08] Kathy on the realities of caring for older adults, especially mobility and inaccessible clinic spaces[00:07:34] Zoe on retention, treatment access barriers, and the strain of co-occurring conditions like cancer and dialysis[00:09:16] Care transitions emerge as a major risk point, especially hospital to skilled nursing to home[00:15:19] Introduction to the geriatric 5Ms: Mobility, Mentation, Medications, Multicomplexity, and What Matters Most[00:23:11] Practical solutions for mobility barriers: medical exceptions, family support, visiting nurses, and dosing flexibility[00:42:28] Closing takeaways: logistical barriers, integrated care, and using age-friendly strategies in OTP settingsLinks Find us online at amersa.org/amersa-podcast  Frontiers in Substance Use & Stigma & Substance Use are sponsored by Provider’s Clinical Support System – Medication for Opioid Use Disorder (PCSS-MOUD). Learn more about PCSS-MOUD at pcssnow.org. Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Substance Use Across the Lifespan and Innovation in Action are sponsored by the Opioid Response Network (ORN). Learn more about ORN at opioidresponsenetwork.org. Funding for this initiative was made possible (in part) by grant no. 1H79TI088037 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

    47 min
  2. Kimber King, Tj Thompson and Dr. Ruchi Shah, SafeSpot Hotline: Virtual Spotting and Real-Time Overdose Prevention

    10/02/2025

    Kimber King, Tj Thompson and Dr. Ruchi Shah, SafeSpot Hotline: Virtual Spotting and Real-Time Overdose Prevention

    SafeSpot Overdose Prevention Hotline provides free, 24/7 virtual spotting services to people who use drugs alone. Born out of the grassroots Never Use Alone Massachusetts line, SafeSpot has evolved into a nationally recognized program housed at Boston Medical Center. In this episode, host Dr. Ruchi Shah speaks with Kimber King and TJ Thompson about SafeSpot’s journey from a volunteer-run initiative to a fully funded overdose prevention organization. Together, they discuss the importance of lived experience, lessons learned from rapid growth, and how SafeSpot is saving lives while challenging stigma, health disparities, and overdose risk in both urban and rural communities. Learning Objectives Identify the risks of using substances alone and how virtual spotting addresses these risks.Analyze how stigma, isolation, and health disparities contribute to overdose deaths.Apply strategies for integrating hotline models like SafeSpot into clinical and community settings, including rural areas.Demonstrate how to do a warm handoff to SafeSpot in a traditional healthcare settingHost & Guest Bios Ruchi Shah, DO (she/her) is an Assistant Professor of Medicine in the Division of General Internal Medicine at Montefiore Medical Center & Albert Einstein College of Medicine. She is the medical director of the Wakefield Hospital Addiction Medicine Consult Service and also provides primary care, addiction medicine, and reproductive healthcare outpatient. Ruchi strives to turn her big feelings into meaningful change and is grateful for the privilege of partnering with and learning from PWUD in their care.Kimber King (she/her) is the Operations Coordinator for the SafeSpot Overdose Hotline, an innovative virtual “spotting” service based at Boston Medical Center. A drug war and overdose survivor, she brings both lived experience and leadership to her work supporting people who use drugs and expanding access to overdose prevention services. Kimber’s story was featured on This American Life (“The Call”), and today she channels her journey into building workforce capacity, training operators, and advocating for practical overdose prevention strategies that save lives. She is also pursuing a Community Health Worker Certificate at the Community College of Vermont, further grounding her commitment to community health and meaningful change.Tj Thompson (they/them) is the Safety Coordinator at SafeSpot OFind us online at amersa.org/amersa-podcast  Frontiers in Substance Use & Stigma & Substance Use are sponsored by Provider’s Clinical Support System – Medication for Opioid Use Disorder (PCSS-MOUD). Learn more about PCSS-MOUD at pcssnow.org. Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Substance Use Across the Lifespan and Innovation in Action are sponsored by the Opioid Response Network (ORN). Learn more about ORN at opioidresponsenetwork.org. Funding for this initiative was made possible (in part) by grant no. 1H79TI088037 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

    54 min
  3. Dr. Emily Skogrand, Dr. Mike Winer and Dr. Honora Englander, Methadone Outside of an OTP: Meeting People Where They Are

    09/18/2025

    Dr. Emily Skogrand, Dr. Mike Winer and Dr. Honora Englander, Methadone Outside of an OTP: Meeting People Where They Are

    Medications methadone and buprenorphine – are the most effective treatments for opioid use disorder. Decades of evidence show that they treat acute withdrawal and cravings, improve quality of life, reduce risk for HIV and hepatitis C, reduce overdose, and reduce risk of drug-related and all-cause mortality. Yet in the US, fewer than 1 in 5 people with OUD accesses them. In the US, Methadone is regulated unlike any other medication, including methadone for pain. With a few exceptions, in ambulatory settings, methadone must be administered from an opioid treatment program – a highly regulated addiction treatment setting. This episode talks with two clinical innovators who are leading work to bring methadone into critical access points in the SUD care continuum – withdrawal management settings and the hospital. Learning Objectives Describe the importance of utilizing methadone in withdrawal management settings and at hospital discharge.Provide practical guidance to develop processes to implement methadone administration/ dispensation via the 72h rule in non-OTP settings, drawing on experience from withdrawal management and hospital settings.Describe some potential challenges and examples of how to address them.Show what 72-hour methadone dispense has potential to achieve in withdrawal management and hospital settings.Host & Guest Bios Dr. Honora Englander is founder and Principal Investigator of the Improving Addiction Care Team (IMPACT), a nationally recognized model for hospital-based addiction care that includes physicians, social workers, and peers with lived experience in recovery. Dr Englander's work is at the intersection of addiction, health system transformation, and public health.Dr. Mike Winer serves as the Medical Director of a withdrawal management center in Portland, Oregon, and is an Assistant Professor in the Section of Addiction Medicine at Oregon Health & Science University. His work focuses on clinical innovation aimed at breaking down barriers to substance use care.Emily Skogrand, PharmD, is a clinical pharmacist at Oregon Health and Science University in Portland, Oregon. She works with the inpatient Internal Medicine department and on the addiction consult service with a special interest in optimizing care for patients with substance use disorders.Timestamps: 00:00:00 — Intro, sponsors, goals00:01:00Find us online at amersa.org/amersa-podcast  Frontiers in Substance Use & Stigma & Substance Use are sponsored by Provider’s Clinical Support System – Medication for Opioid Use Disorder (PCSS-MOUD). Learn more about PCSS-MOUD at pcssnow.org. Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Substance Use Across the Lifespan and Innovation in Action are sponsored by the Opioid Response Network (ORN). Learn more about ORN at opioidresponsenetwork.org. Funding for this initiative was made possible (in part) by grant no. 1H79TI088037 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

    38 min
  4. Johanna Sluser, Kelly Brandon, and Kristin Wason, ACT Now: Advancing Hospital Addiction Care Through a Nurse Liaison Program

    09/04/2025

    Johanna Sluser, Kelly Brandon, and Kristin Wason, ACT Now: Advancing Hospital Addiction Care Through a Nurse Liaison Program

    This episode explores the Addiction Care Team Nurse Liaison Program (ACTNLP), a program that equips hospital nurses with substance use disorder (SUD) training to reduce stigma and improve outcomes for patients with SUD. Developed within an urban safety-net hospital, the program includes didactics, precepting with addiction specialists, and community site visits. Participants become SUD champions, educators, and leaders on their units. Early outcomes show high program completion and addiction certification rates, strong curriculum relevance, and improved knowledge and engagement. ACTNLP is a feasible, scalable model to enhance nursing capacity to provide addiction care in hospital settings. Learning Objectives Describe the core components of the ACTNL program training and the ACTNL role in clinical implementation on the unit.Identify key benefits of training nurses in evidence-based addiction care, including impacts on patient outcomes, interdisciplinary communication, and stigma reduction.Recognize the value of the ACTNL program in its efforts to enhance nursing addiction education.Identify barriers to implementing nurse-led addiction training programs and explore strategies to overcome them.Assess potential for adaptation in diverse healthcare settings.Host & Guest Bios Kristin Wason, MSN, NP-C, CARN, is a Nurse Practitioner at Boston Medical Center and serves as the Director of the Grayken Addiction Nursing Fellowship, the first addiction fellowship program for registered nurses in the United States. Kristin has experience working in numerous addiction treatment settings and currently provides direct patient care as a member of BMC’s Behavior Response Team and as a methadone provider at HCRC Boston. Kristin has published in several peer reviewed journals and is first author of Addiction Nursing Competencies: A Comprehensive Toolkit for the Addictions Nurse. She has also co-authored and authored numerous guidelines to treat patients with substance use disorders in the outpatient setting.Kelly Brandon, MSN, RNC, CNS, IBCLC, CARN, works as a Perinatal Clinical Nurse Specialist at San Francisco General Hospital. Prior to her nursing work she was a counselor and program manager for a street outreach program in San Francisco. In her role as the Co-Director of the ACTNL program she aims to bring evidence-based, easy to access, compassionate care to all patients thFind us online at amersa.org/amersa-podcast  Frontiers in Substance Use & Stigma & Substance Use are sponsored by Provider’s Clinical Support System – Medication for Opioid Use Disorder (PCSS-MOUD). Learn more about PCSS-MOUD at pcssnow.org. Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Substance Use Across the Lifespan and Innovation in Action are sponsored by the Opioid Response Network (ORN). Learn more about ORN at opioidresponsenetwork.org. Funding for this initiative was made possible (in part) by grant no. 1H79TI088037 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

    40 min
  5. Dr. Holly Drone & Dr. Timothy Kummer, Beyond Overdose: Integrating Buprenorphine into EMS for Lasting Impact

    08/21/2025

    Dr. Holly Drone & Dr. Timothy Kummer, Beyond Overdose: Integrating Buprenorphine into EMS for Lasting Impact

    In this episode, host Dr. Tim Kummer is joined by Holly Drone, EMS Pharmacist, and Jackson Thiets, paramedic and buprenorphine advocate with the Hennepin EMS Bridge Program. Together, they share the journey of implementing a paramedic-driven buprenorphine protocol, the lessons learned from their first year, and how the program has evolved to include holistic post-overdose care. The conversation highlights barriers faced, culture shifts needed in EMS and ED settings, and how moving from judgment to empathy—and empathy to action—can transform care for patients with opioid use disorder. Learning Objectives Describe the development and implementation of a paramedic-driven buprenorphine protocol in a large urban EMS system, including the clinical rationale, training structure, and system-level logistics.Identify common barriers to prehospital buprenorphine use—such as stigma, protocol hesitancy, and supply chain issues—and explore practical strategies for overcoming them through clinical leadership and team buy-in.Understand the role of interdisciplinary collaboration—between EMS, pharmacists, and peer support specialists—in creating a holistic, post-overdose care model like the Hennepin EMS Bridge Program.Recognize how EMS and Emergency Departments can move from judgment-based responses to compassionate, action-oriented care for patients with opioid use disorder, reframing naloxone-only approaches to include long-term treatment initiation.Host & Guest Bios Host- Dr. Tim Kummer is an Emergency Physician and EMS Medical Director at Hennepin Healthcare, where he leads several initiatives focused on addressing the opioid crisis. He founded the Hennepin Bridge Program, an innovative team that connects patients with opioid use disorder to treatment through ED consults, field buprenorphine inductions, and follow-up care. Dr. Kummer also helped launch one of the first prehospital buprenorphine programs in the country and serves on the National Association of EMS Physicians work group developing national guidance on EMS’s role in the opioid epidemic. His work is grounded in bringing care directly to patients—whether in the field, at home, or in the emergency department—and meeting them where they are on their journey to recovery.Holly Drone, PharmD, is a Clinical Pharmacist at Hennepin Healthcare and Hennepin EMS specializing in emergency medicine and prehospital emergency care. She supports a Find us online at amersa.org/amersa-podcast  Frontiers in Substance Use & Stigma & Substance Use are sponsored by Provider’s Clinical Support System – Medication for Opioid Use Disorder (PCSS-MOUD). Learn more about PCSS-MOUD at pcssnow.org. Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Substance Use Across the Lifespan and Innovation in Action are sponsored by the Opioid Response Network (ORN). Learn more about ORN at opioidresponsenetwork.org. Funding for this initiative was made possible (in part) by grant no. 1H79TI088037 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

    47 min
  6. Phil McNamara, Bella Wilklow, and Elizabeth Abbs, Enhancing Treatment Access: How collaboration with multidisciplinary providers and community members increases connection to long term care.

    08/07/2025

    Phil McNamara, Bella Wilklow, and Elizabeth Abbs, Enhancing Treatment Access: How collaboration with multidisciplinary providers and community members increases connection to long term care.

    This episode will focus on the outreach and support service efforts within MATTERS that address barriers to treatment for opioid use disorder. While MATTERS is widely recognized for its harm reduction efforts, this episode will dig deeper into the essential support structures that make treatment more accessible, which can enhance the likelihood of a successful connection once referrals are made. The episode will cover how the program uses emergency telemedicine, peer networks, and wraparound programs to address barriers such as lack of insurance, transportation, and stigma. Additionally, it will discuss how follow-up with individuals navigating treatment helps to inform decision-making when it comes to the services MATTERS offers and how they communicate and interact with providers and partnering organizations Learning Objectives Identify means of creating a tailored referral system that streamlines connection to addiction medicine after jail or hospitalization to reduce barriers for patients seeking medications for OUDDemonstrate the critical role of community health navigation in successful care linkageHost & Guest Bios Dr. Elizabeth Abbs is a primary care addiction medicine provider in San Francisco. She cares for a complex cohort of patients who live in the Tenderloin neighborhood - many of whom use drugs. Her work at the San Francisco Department of Public Health focuses on reducing barriers to care for patients accessing medications for their substance use disorder, incentivizing harm reduction efforts, and improving safe (and compassionate) prescribing of controlled medications for chronic pain.Phil McNamara is the Outreach Manager at MATTERS Network. Leading a team of Regional Outreach Coordinators across NYS, connecting individuals to outpatient follow-up care and harm reduction resources. He has a background as an SUD Counselor specializing in MOUD at a Buffalo-based OTP, and as a Community Outreach Coordinator specializing in HCV Linkage and Harm Reduction. Phil is the founder of Buffalo Resilience a nonprofit providing meals and harm reduction supplies & training to underserved communities in WNY. He believes that a strong community can offer many different paths to recovery and is passionate about building strong community connections.Isabella Wilklow is the Support Services Coordinator at MATTERS, where she assists individuals seeking connection to treatment for opioid usFind us online at amersa.org/amersa-podcast  Frontiers in Substance Use & Stigma & Substance Use are sponsored by Provider’s Clinical Support System – Medication for Opioid Use Disorder (PCSS-MOUD). Learn more about PCSS-MOUD at pcssnow.org. Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Substance Use Across the Lifespan and Innovation in Action are sponsored by the Opioid Response Network (ORN). Learn more about ORN at opioidresponsenetwork.org. Funding for this initiative was made possible (in part) by grant no. 1H79TI088037 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

    39 min

  7. 07/24/2025

    Dr. Triveni DeFries, Dairo Romero and Dr. Marlene Martin, Promoting health: Community health workers address unhealthy substance use

    The Program for Education in Drugs and Alcohol for Latine (PEDAL) is an example of a partnership between community-based organizations and addiction medicine clinicians. In this episode the guest discuss their collaboration to co-develop a training program for promotores, also known as community health workers, to address unhealthy substance use in the Latine community, offering a model for building workforce capacity to address increasing rates of overdose amongst Latine in a culturally and linguistically informed approach. Learning Objectives Demonstrate how to develop a collaborative partnership with community-based organizations to build workforce capacity.Identify the factors for effective implementation of a curriculum for community health workers.Name a strength to building the capacity of community health workers to address substance use.Host & Guest Bios Host: Marlene Martin, MD, is an Associate Professor of Clinical Medicine at UCSF, Director of Addiction Initiatives for the Latinx Center of Excellence, a hospitalist at San Francisco General Hospital (SFGH), and Director of the Addiction Care Team (ACT) at SFGH. Drawn to medicine to address health inequities and social injustices, her interests lie in systems improvement and innovation with a focus on addiction, community partnerships, Latine health, and care transitions. Marlene is committed to transforming systems of care to improve health outcomes for marginalized communities and ensuring that addiction care is compassionate, accessible, and equitable. She co-leads the Program for Education on Drugs and Alcohol for Latine (PEDAL).Triveni DeFries, MD, MPH is a physician and Assistant Professor at the University of California, San Francisco and Core Faculty in the Institute of Global Health Sciences. She practices internal medicine and addiction medicine at San Francisco General Hospital. She is a clinician consultant on the Substance Use Warmline for the National Clinician Consultation Center. She co-leads the Program for Education on Drugs and Alcohol for Latine (PEDAL).Dairo Romero is an immigrant from Colombia with a lifelong passion for social justice, community empowerment, and equity for immigrant and Latino communities. He is Community Initiatives Manager at Mission Economic Development Agency in San Francisco, where he works to advocate for affordable housing in the Mission District. There, he supports families Find us online at amersa.org/amersa-podcast  Frontiers in Substance Use & Stigma & Substance Use are sponsored by Provider’s Clinical Support System – Medication for Opioid Use Disorder (PCSS-MOUD). Learn more about PCSS-MOUD at pcssnow.org. Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Substance Use Across the Lifespan and Innovation in Action are sponsored by the Opioid Response Network (ORN). Learn more about ORN at opioidresponsenetwork.org. Funding for this initiative was made possible (in part) by grant no. 1H79TI088037 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

    45 min
  8. Dr. Carrie Wilkens, Dr. Brandee Madden, & Dr. Jeff Foote. Stigmatized by Association- Impact of SUD and Stigma on Families

    07/17/2025

    Dr. Carrie Wilkens, Dr. Brandee Madden, & Dr. Jeff Foote. Stigmatized by Association- Impact of SUD and Stigma on Families

    This episode explores the "contagious" nature of stigma in substance use disorders (SUDs), revealing how shame and discrimination spread beyond the 45-50 million Americans with SUDs to affect an estimated 45-300 million family members. While stigma's impact on individuals with SUDs is well-documented, this conversation spotlights how families become "stigmatized by association," driving them "underground" and leading to isolation, delayed help-seeking, compromised mental health, strained relationships, and poorer recovery outcomes for the entire family system. Learning Objectives Identify at least three ways stigma impacts family members of individuals with substance use disorders, including specific effects on mental/physical health, help-seeking behaviors, and family dynamics.Analyze how "stigma by association" creates unique barriers for families in accessing support and contributing to their loved one's change process.Apply evidence-based communication strategies to reduce stigma when interacting with families affected by substance use disorders in professional or community settings.Host & Guest Bios Dr. Brandee Madden is an Assistant Professor at Vanderbilt University School of Nursing. She is an experienced nursing educator and psychiatric mental health nurse practitioner who has provided treatment for mental health and substance use disorders in the community for over 15 years. Her clinical expertise is in the treatment of tobacco use in individuals with mental health and substance use disorders.Dr. Jeff Foote is a psychologist and nationally-recognized clinical researcher with over 30 years of experience in evidence-based treatment for substance use disorders and trauma. He has been driving change in the field of addiction treatment as Co-President and CEO of CMC:Foundation for Change, Co-Founder of the Center for Motivation and Change and co-author of the award-winning books "Beyond Addiction: How Science and Kindness Help People Change" and "The Beyond Addiction Workbook for Family and Friends."Dr. Carrie Wilkens is a psychologist with over 20 years of experience in substance use, trauma treatment, and working with families of those struggling with substance use. She is the Co-Founder and President of the non-profit, CMC:Foundation for Change, and Co-Founder of the Center for Motivation and Change treatment network and the co-author of the award-winning books "Beyond AddiFind us online at amersa.org/amersa-podcast  Frontiers in Substance Use & Stigma & Substance Use are sponsored by Provider’s Clinical Support System – Medication for Opioid Use Disorder (PCSS-MOUD). Learn more about PCSS-MOUD at pcssnow.org. Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Substance Use Across the Lifespan and Innovation in Action are sponsored by the Opioid Response Network (ORN). Learn more about ORN at opioidresponsenetwork.org. Funding for this initiative was made possible (in part) by grant no. 1H79TI088037 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

    50 min
See All (16)

About

Two new Series Coming Soon in 2026!Frontiers in Substance Use Care: Emerging Topics and Evidence Eight episode podcast series sponsored by Provider’s Clinical Support System – Medication for Opioid Use Disorder (PCSS-MOUD), exploring the evolving landscape of substance use and addiction care.Substance Use Across the Lifespan: Supporting Every Stage Five episodes, each paired with a downloadable toolkit and live companion workshop, sponsored by the Opioid Response Network (ORN). This series explores how substance use care changes across the lifespan—from childhood through older adulthood. Previous SeriesStigma and Substance Use: Rewriting the Narrative.  Eight episodes sponsored by Provider’s Clinical Support System – Medication for Opioid Use Disorder (PCSS-MOUD), exploring the pervasive impact of stigma on individuals and communities affected by substance use disorders (SUD). Innovation in Action: Building Stronger CommunitiesSeven episodes sponsored by the Opioid Response Network (ORN), highlighting cutting-edge programs and collaborative efforts supporting individuals and communities affected by substance use disorders. 

Information

  • Creator
    AMERSA
  • Years Active
    2025 - 2026
  • Episodes
    16
  • Rating
    Clean
  • Copyright
    © 2026 AMERSA Talks
  • Show Website
    AMERSA Talks